Area of research
Hematology · Oncology
Research interest
Research interests include Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Cancer Treatment and Pharmacology, and Peptidase Inhibition and Analysis.
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study
Resolving the spatial architecture of myeloma and its microenvironment at the single-cell level
The spatio-temporal evolution of multiple myeloma from baseline to relapse-refractory states
Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level
Bone marrow microenvironments that contribute to patient outcomes in newly diagnosed multiple myeloma: A cohort study of patients in the Total Therapy clinical trials
A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry
Visualizing collagen proteolysis by peptide hybridization: From 3D cell culture to in vivo imaging
Low expression of hexokinase-2 is associated with false-negative FDG–positron emission tomography in multiple myeloma
NEK2 Induces Drug Resistance Mainly through Activation of Efflux Drug Pumps and Is Associated with Poor Prognosis in Myeloma and Other Cancers
Could hypoxia increase the prevalence of thrombotic complications in polycythemia vera?
A Meta-Analysis Of Genome-Wide Association Studies Of Multiple Myeloma In Cases and Controls Of European Origin Identifies a Risk Locus In 12q23.1
Impact of bortezomib on bone health in myeloma: A review of current evidence
Effect of time to infusion of autologous stem cells (24 vs. 48 h) after high‐dose melphalan in patients with multiple myeloma